4,797
Views
23
CrossRef citations to date
0
Altmetric
Reviews - Solicited

Immunotherapy of house dust mite allergy

&
Pages 2390-2396 | Received 15 May 2017, Accepted 03 Aug 2017, Published online: 18 Oct 2017

References

  • Dust mite allergens and asthma–a worldwide problem. J Allergy Clin Immunol. 1989;83(2 Pt 1):416-27.
  • Frankland AW. Asthma and mites. Postgrad Med J. 1971;47(545):178-80.
  • Bousquet J , Dahl R , Khaltaev N . Global Alliance against Chronic Respiratory Diseases. Eur Respir J. 2007;29(2):233-9. PMID:17264322
  • Bateman ED , Hurd SS , Barnes PJ , et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31(1):143-78. PMID:18166595
  • Chen J , Zhao Y , Li B , Zhang Q , Wan L , Liu J , Tian X , Li G , Zhou J , Zhang L et al. A multicenter study of the clinical features of allergic rhinitis in central China. Am J Rhinol Allergy. 2014;28(5):392-6. PMID:25198025
  • Adham TM , Tawfik SA , Abdo NM . House dust mites in pediatric atopic dermatitis. Saudi Med J. 2011;32(2):177-82. PMID:21301766
  • Bousquet J , Lockey R , Malling HJ . Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol. 1998;102(4 Pt 1):558-62.
  • Sheikh A , Hurwitz B , Nurmatov U , van Schayck CP . House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev. 2010;(7):D1563.
  • Gotzsche PC , Johansen HK . House dust mite control measures for asthma: systematic review. Allergy. 2008;63(6):646-59. PMID:18445182
  • Bousquet J , Khaltaev N , Cruz AA , Denburg J , Fokkens WJ , Togias A , Zuberbier T , Baena-Cagnani CE , Canonica GW , van Weel C et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63 Suppl 86:8-160. doi:10.1111/j.1398-9995.2007.01620.x. PMID:18331513
  • Inal A , Altintas DU , Yilmaz M , Karakoc GB , Kendirli SG , Sertdemir Y . Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite. J Investig Allergol Clin Immunol. 2007;17(2):85-91. PMID:17460946
  • Jacobsen L , Niggemann B , Dreborg S , Ferdousi HA , Halken S , Høst A , Koivikko A , Norberg LA , Valovirta E , Wahn U et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007;62(8):943-8. doi:10.1111/j.1398-9995.2007.01451.x. PMID:17620073
  • Colloff MJ . Effects of temperature and relative humidity on development times and mortality of eggs from laboratory and wild populations of the European house-dust mite Dermatophagoides pteronyssinus (Acari: Pyroglyphidae). Exp Appl Acarol. 1987;3(4):279-89. doi:10.1007/BF01193165. PMID:3453790
  • Arlian LG , Morgan MS , Neal JS . Dust mite allergens: ecology and distribution. Curr Allergy Asthma Rep. 2002;2(5):401-11. doi:10.1007/s11882-002-0074-2. PMID:12165207
  • Trombone AP , Tobias KR , Ferriani VP , Schuurman J , Aalberse RC , Smith AM , Chapman MD , Arruda LK . Use of a chimeric ELISA to investigate immunoglobulin E antibody responses to Der p 1 and Der p 2 in mite-allergic patients with asthma, wheezing and/or rhinitis. Clin Exp Allergy. 2002;32(9):1323-8. doi:10.1046/j.1365-2745.2002.01455.x. PMID:12220471
  • Jacquet A . Innate immune responses in house dust mite allergy. ISRN Allergy. 2013;2013:735031. doi:10.1155/2013/735031. PMID:23724247
  • Weghofer M , Grote M , Resch Y , Casset A , Kneidinger M , Kopec J , Thomas WR , Fernández-Caldas E , Kabesch M , Ferrara R et al. Identification of Der p 23, a peritrophin-like protein, as a new major Dermatophagoides pteronyssinus allergen associated with the peritrophic matrix of mite fecal pellets. J Immunol. 2013;190(7):3059-67. doi:10.4049/jimmunol.1202288. PMID:23460742
  • Carnes J , Iraola V , Cho SH , Esch RE . Mite allergen extracts and clinical practice. Ann Allergy Asthma Immunol. 2017;118(3):249-56. doi:10.1016/j.anai.2016.08.018. PMID:28284531
  • Allergen products (Producta allergenica) . European Pharmacopeia. 1997:1063-8.
  • Cox L , Jacobsen L . Comparison of allergen immunotherapy practice patterns in the United States and Europe. Ann Allergy Asthma Immunol. 2009;103(6):451-9, 459–61, 495. doi:10.1016/S1081-1206(10)60259-1. PMID:20084837
  • Larenas-Linnemann D , Cox LS . European allergen extract units and potency: review of available information. Ann Allergy Asthma Immunol. 2008;100(2):137-45. doi:10.1016/S1081-1206(10)60422-X. PMID:18320915
  • Pytelkova J , Lepsik M , Sanda M , Talacko P , Maresova L , Mares M . Enzymatic activity and immunoreactivity of Aca s 4, an alpha-amylase allergen from the storage mite Acarus siro. BMC Biochem. 2012;13:3. doi:10.1186/1471-2091-13-3. PMID:22292590
  • Takayama G , Arima K , Kanaji T , Toda S , Tanaka H , Shoji S , McKenzie AN , Nagai H , Hotokebuchi T , Izuhara K . Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol. 2006;118(1):98-104. doi:10.1016/j.jaci.2006.02.046. PMID:16815144
  • Casset A , Mari A , Purohit A , Resch Y , Weghofer M , Ferrara R , Thomas WR , Alessandri C , Chen KW , de Blay F et al. Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts. Int Arch Allergy Immunol. 2012;159(3):253-62. doi:10.1159/000337654. PMID:22722650
  • Alvarez-Cuesta E , Bousquet J , Canonica GW , Durham SR , Malling HJ , Valovirta E . Standards for practical allergen-specific immunotherapy. Allergy. 2006;61 Suppl 82:1-20. doi:10.1111/j.1398-9995.2006.01219_1.x. PMID:16930249
  • Sander I , Fleischer C , Meurer U , Bruning T , Raulf-Heimsoth M . Allergen content of grass pollen preparations for skin prick testing and sublingual immunotherapy. Allergy. 2009;64(10):1486-92. doi:10.1111/j.1398-9995.2009.02040.x. PMID:19385952
  • Calderon MA , Casale TB , Togias A , Bousquet J , Durham SR , Demoly P . Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. J Allergy Clin Immunol. 2011;127(1):30-8. doi:10.1016/j.jaci.2010.08.024. PMID:20965551
  • James LK , Durham SR . Update on mechanisms of allergen injection immunotherapy. Clin Exp Allergy. 2008;38(7):1074-88. doi:10.1111/j.1365-2222.2008.02976.x. PMID:18691292
  • van de Veen W , Stanic B , Yaman G , Wawrzyniak M , Söllner S , Akdis DG , Rückert B , Akdis CA , Akdis M . IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol. 2013;131(4):1204-12. doi:10.1016/j.jaci.2013.01.014. PMID:23453135
  • Gold MJ , Antignano F , Halim TY , Hirota JA , Blanchet MR , Zaph C , Takei F , McNagny KM . Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. J Allergy Clin Immunol. 2014;133(4):1142-8. doi:10.1016/j.jaci.2014.02.033. PMID:24679471
  • Scadding G , Durham S . Mechanisms of sublingual immunotherapy. J Asthma. 2009;46(4):322-34. doi:10.1080/02770900902785729. PMID:19484663
  • Eifan AO , Calderon MA , Durham SR . Allergen immunotherapy for house dust mite: clinical efficacy and immunological mechanisms in allergic rhinitis and asthma. Expert Opin Biol Ther. 2013;13(11):1543-56. doi:10.1517/14712598.2013.844226. PMID:24099116
  • Calderon MA , Casale TB , Nelson HS , Demoly P . An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies. J Allergy Clin Immunol. 2013;132(6):1322-36. doi:10.1016/j.jaci.2013.09.004. PMID:24139829
  • Erekosima N , Suarez-Cuervo C , Ramanathan M , Kim JM , Chelladurai Y , Segal JB , Lin SY . Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review. Laryngoscope. 2014;124(3):616-27. doi:10.1002/lary.24295. PMID:23832632
  • Lu Y , Xu L , Xia M , Li Y , Cao L . The efficacy and safety of subcutaneous immunotherapy in mite-sensitized subjects with asthma: a meta-analysis. Respir Care. 2015;60(2):269-78. doi:10.4187/respcare.03399. PMID:25389355
  • Abramson MJ , Puy RM , Weiner JM . Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev. 2010;(8):D1186.
  • Radulovic S , Calderon MA , Wilson D , Durham S . Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev. 2010;(12):D2893.
  • Compalati E , Passalacqua G , Bonini M , Canonica GW . The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis. Allergy. 2009;64(11):1570-9. doi:10.1111/j.1398-9995.2009.02129.x. PMID:19796205
  • Calamita Z , Saconato H , Pela AB , Atallah AN . Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method. Allergy. 2006;61(10):1162-72. doi:10.1111/j.1398-9995.2006.01205.x. PMID:16942563
  • Nolte H , Maloney J , Nelson HS , et al. Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber. J Allergy Clin Immunol. 2015;135(6):1494-501. doi:10.1016/j.jaci.2014.12.1911. PMID:25636947
  • Bergmann KC , Demoly P , Worm M , Fokkens WJ , Carrillo T , Tabar AI , Nguyen H , Montagut A , Zeldin RK . Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis. J Allergy Clin Immunol. 2014;133(6):1608-14. doi:10.1016/j.jaci.2013.11.012. PMID:24388010
  • Mosbech H , Deckelmann R , de Blay F , et al. Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2014;134(3):568-75. doi:10.1016/j.jaci.2014.03.019. PMID:24797423
  • Feng B , Xiang H , Jin H , Gao J , Huang S , Shi Y , Chen R , Chen B . Efficacy of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis: A Meta-Analysis of Randomized Controlled Trials. Allergy Asthma Immunol Res. 2017;9(3):220-8. doi:10.4168/aair.2017.9.3.220. PMID:28293928
  • Calderon MA , Casale TB , Nelson HS , Demoly P . An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies. J Allergy Clin Immunol. 2013;132(6):1322-36. doi:10.1016/j.jaci.2013.09.004. PMID:24139829
  • Virchow JC , Backer V , Kuna P , Prieto L , Nolte H , Villesen HH , Ljørring C , Riis B , de Blay F . Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial. JAMA. 2016;315(16):1715-25. doi:10.1001/jama.2016.3964. PMID:27115376
  • Demoly P , Emminger W , Rehm D , Backer V , Tommerup L , Kleine-Tebbe J . Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial. J Allergy Clin Immunol. 2016;137(2):444-51. doi:10.1016/j.jaci.2015.06.036. PMID:26292778
  • Eifan AO , Akkoc T , Yildiz A , Keles S , Ozdemir C , Bahceciler NN , Barlan IB . Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial. Clin Exp Allergy. 2010;40(6):922-32. doi:10.1111/j.1365-2222.2009.03448.x. PMID:20100188
  • Keles S , Karakoc-Aydiner E , Ozen A , Izgi AG , Tevetoglu A , Akkoc T , Bahceciler NN , Barlan I . A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes. J Allergy Clin Immunol. 2011;128(4):808-15. doi:10.1016/j.jaci.2011.04.033. PMID:21641635
  • Piazza I , Bizzaro N . Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus. Ann Allergy. 1993;71(5):461-9. PMID:7755664
  • Mungan D , Misirligil Z , Gurbuz L . Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma–a placebo controlled study. Ann Allergy Asthma Immunol. 1999;82(5):485-90. doi:10.1016/S1081-1206(10)62726-3. PMID:10353581
  • Wood RA . New Horizons in Allergen Immunotherapy. JAMA. 2016;315(16):1711-2. doi:10.1001/jama.2016.4078. PMID:27115374
  • Lee J , Lee H , Noh S , Bae BG , Shin JU , Park CO , Lee KH . Retrospective Analysis on the Effects of House Dust Mite Specific Immunotherapy for More Than 3 Years in Atopic Dermatitis. Yonsei Med J. 2016;57(2):393-8. doi:10.3349/ymj.2016.57.2.393. PMID:26847292
  • Bae JM , Choi YY , Park CO , Chung KY , Lee KH . Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol. 2013;132(1):110-7. doi:10.1016/j.jaci.2013.02.044. PMID:23647790
  • Novak N , Bieber T , Hoffmann M , Fölster-Holst R , Homey B , Werfel T , Sager A , Zuberbier T . Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. J Allergy Clin Immunol. 2012;130(4):925-31. doi:10.1016/j.jaci.2012.08.004. PMID:22947344
  • Lee J , Park CO , Lee KH . Specific immunotherapy in atopic dermatitis. Allergy Asthma Immunol Res. 2015;7(3):221-9. doi:10.4168/aair.2015.7.3.221. PMID:25749758
  • Des Roches A , Paradis L , Knani J , Hejjaoui A , Dhivert H , Chanez P , Bousquet J . Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. V. Duration of the efficacy of immunotherapy after its cessation. Allergy. 1996;51(6):430-3.
  • Marogna M , Spadolini I , Massolo A , Canonica GW , Passalacqua G . Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study. J Allergy Clin Immunol. 2010;126(5):969-75. doi:10.1016/j.jaci.2010.08.030. PMID:20934206
  • Des Roches A, Paradis L , Menardo JL , Bouges S , Daures JP , Bousquet J . Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol. 1997;99(4):450-3.
  • Zolkipli Z , Roberts G , Cornelius V , Clayton B , Pearson S , Michaelis L , Djukanovic R , Kurukulaaratchy R , Arshad SH . Randomized controlled trial of primary prevention of atopy using house dust mite allergen oral immunotherapy in early childhood. J Allergy Clin Immunol. 2015;136(6):1541-7. doi:10.1016/j.jaci.2015.04.045. PMID:26073754
  • Passalacqua G , Baena-Cagnani CE , Bousquet J , Canonica GW , Casale TB , Cox L , Durham SR , Larenas-Linnemann D , Ledford D , Pawankar R et al. Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. J Allergy Clin Immunol. 2013;132(1):93-8. doi:10.1016/j.jaci.2013.03.039. PMID:23683513
  • Cox L , Larenas-Linnemann D , Lockey RF , Passalacqua G . Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. J Allergy Clin Immunol. 2010;125(3):569-74, 571–4. doi:10.1016/j.jaci.2009.10.060. PMID:20144472
  • Kelso JM . The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reaction. Ann Allergy Asthma Immunol. 2004;92(2):225-7. doi:10.1016/S1081-1206(10)61551-7. PMID:14989390
  • Dong X , Huang N , Li W , Hu L , Wang X , Wang Y , Xiang N , Liu G , Zhu R . Systemic Reactions to Dust Mite Subcutaneous Immunotherapy: A 3-Year Follow-up Study. Allergy Asthma Immunol Res. 2016;8(5):421-7. doi:10.4168/aair.2016.8.5.421. PMID:27334780
  • Epstein TG , Liss GM , Murphy-Berendts K , Bernstein DI . AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008–2012: an update on fatal and nonfatal systemic allergic reactions. J Allergy Clin Immunol Pract. 2014;2(2):161-7. doi:10.1016/j.jaip.2014.01.004. PMID:24607043
  • Cox LS , Larenas LD , Nolte H , Weldon D , Finegold I , Nelson HS . Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol. 2006;117(5):1021-35. doi:10.1016/j.jaci.2006.02.040. PMID:16675328
  • Calderon MA , Simons FE , Malling HJ , Lockey RF , Moingeon P , Demoly P . Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile. Allergy. 2012;67(3):302-11. doi:10.1111/j.1398-9995.2011.02761.x. PMID:22150126
  • Mahler V , Klein C , Sager A , Zimmermann J . House dust mite-specific immunotherapy with two licensed vaccines: Outcome under clinical routine conditions. Immun Inflamm Dis. 2017;5(2):132-40. doi:10.1002/iid3.141. PMID:28474505
  • Devillier P , Fadel R , de Beaumont O . House dust mite sublingual immunotherapy is safe in patients with mild-to-moderate, persistent asthma: a clinical trial. Allergy. 2016;71(2):249-57. doi:10.1111/all.12791. PMID:26465232
  • Cox LS , Larenas LD , Nolte H , Weldon D , Finegold I , Nelson HS . Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol. 2006;117(5):1021-35. doi:10.1016/j.jaci.2006.02.040. PMID:16675328
  • Okubo K , Masuyama K , Imai T , Okamiya K , Stage BS , Seitzberg D , Konno A . Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis. J Allergy Clin Immunol. 2017;139(6):1840-1848. PMID:27864024
  • Nolte H , Bernstein DI , Nelson HS , Kleine-Tebbe J , Sussman GL , Seitzberg D , Rehm D , Kaur A , Li Z , Lu S . Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2016;138(6):1631-8. doi:10.1016/j.jaci.2016.06.044. PMID:27521719
  • Cox L , Nelson H , Lockey R , Kleine-Tebbe J , Sussman GL , Seitzberg D , Rehm D , Kaur A , Li Z , Lu S . Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011;127(1 Suppl):S1-55. doi:10.1016/j.jaci.2010.09.034. PMID:21122901
  • Esch RE . Allergen immunotherapy: what can and cannot be mixed? J Allergy Clin Immunol. 2008;122(3):659-60. doi:10.1016/j.jaci.2008.07.018. PMID:18774400
  • Nony E , Martelet A , Jain K , Moingeon P . Allergen extracts for immunotherapy: to mix or not to mix? Expert Rev Clin Pharmacol. 2016;9(3):401-8. doi:10.1586/17512433.2015.1131122. PMID:26652799
  • Cox L , Esch RE , Corbett M , Hankin C , Nelson M , Plunkett G . Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes. Ann Allergy Asthma Immunol. 2011;107(4):289-99, 300. doi:10.1016/j.anai.2011.06.018. PMID:21962088
  • Hankin CS , Cox L . Allergy immunotherapy: what is the evidence for cost saving? Curr Opin Allergy Clin Immunol. 2014;14(4):363-70. doi:10.1097/ACI.0000000000000084. PMID:24936851
  • Petersen KD , Gyrd-Hansen D , Dahl R . Health-economic analyses of subcutaneous specific immunotherapy for grass pollen and mite allergy. Allergol Immunopathol (Madr). 2005;33(6):296-302. doi:10.1016/S0301-0546(05)73246-8. PMID:16371215
  • Green W , Kleine-Tebbe J , Klimek L , Hahn-Pedersen J , Norgaard AJ , Taylor M . Cost-effectiveness of SQ(R) HDM SLIT-tablet in addition to pharmacotherapy for the treatment of house dust mite allergic rhinitis in Germany. Clinicoecon Outcomes Res. 2017;9:77-84. doi:10.2147/CEOR.S115931. PMID:28243132
  • Cox L . Allergy immunotherapy in reducing healthcare cost. Curr Opin Otolaryngol Head Neck Surg. 2015;23(3):247-54. doi:10.1097/MOO.0000000000000150. PMID:25887973
  • Lee SP , Choi SJ , Joe E , Lee SM , Lee MW , Shim JW , Kim YJ , Kyung SY , Park JW , Jeong SH , Jung JH . A Pilot Study of Intralymphatic Immunotherapy for House Dust Mite, Cat, and Dog Allergies. Allergy Asthma Immunol Res. 2017;9(3):272-7. doi:10.4168/aair.2017.9.3.272. PMID:28293934
  • Massanari M , Nelson H , Casale T , Busse W , Kianifard F , Geba GP , Zeldin RK . Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma. J Allergy Clin Immunol. 2010;125(2):383-9. doi:10.1016/j.jaci.2009.11.022. PMID:20159249
  • Massanari M , Nelson H , Casale T , Busse W , Kianifard F , Geba GP , Zeldin RK . Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma. J Allergy Clin Immunol. 2010;125(2):383-9. doi:10.1016/j.jaci.2009.11.022. PMID:20159249
  • Pulsawat P , Piboonpocanun S , Sirivichayakul S , Buranapraditkun S , Jacquet A , Shimada M , Okuda K , Ruxrungtham K . Production and immunogenicity of hypoallergenic codon-optimized DNA vaccine encoding mature Der p 1 allergen. J Investig Allergol Clin Immunol. 2010;20(7):582-90. PMID:21313999
  • Banerjee S , Weber M , Blatt K , Swoboda I , Focke-Tejkl M , Valent P , Valenta R , Vrtala S . Conversion of Der p 23, a new major house dust mite allergen, into a hypoallergenic vaccine. J Immunol. 2014;192(10):4867-75. doi:10.4049/jimmunol.1400064. PMID:24733847
  • Calderon MA , Demoly P , Gerth VWR , Bousquet J , Sheikh A , Frew A , Scadding G , Bachert C , Malling HJ , Valenta R et al. EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy. Clin Transl Allergy. 2012;2(1):20.
  • Jutel M , Jaeger L , Suck R , Meyer H , Fiebig H , Cromwell O . Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol. 2005;116(3):608-13. doi:10.1016/j.jaci.2005.06.004. PMID:16159631
  • Pauli G , Larsen TH , Rak S , Horak F , Pastorello E , Valenta R , Purohit A , Arvidsson M , Kavina A , Schroeder JW . Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2008;122(5):951-60. doi:10.1016/j.jaci.2008.09.017. PMID:19000581
  • Patel D , Couroux P , Hickey P , Salapatek AM , Laidler P , Larché M , Hafner RP . Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study. J Allergy Clin Immunol. 2013;131(1):103-9. doi:10.1016/j.jaci.2012.07.028. PMID:22981787
  • Bachert C , Larche M , Bonini S , et al. Allergen immunotherapy on the way to product-based evaluation-a WAO statement. World Allergy Organ J. 2015;8(1):29. doi:10.1186/s40413-015-0078-8. PMID:26417398